From Medscape Oncology

Coverage from the

World Conference on Lung Cancer (WCLC) 2022

August 06 - 09, 2022; Vienna, Austria and Virtual/Online

August 06 - 09, 2022 Vienna, Austria and Virtual/Online

WCLC 2022 Air Pollution Contribution to Lung Cancer May Be Underestimated New data comes from a Canadian study of patients diagnosed with lung cancer who had never smoked but who migrated from regions where heavy air pollution is the norm.
MDedge News, August 12, 2022

Conference News

Most Younger Adults With Lung Cancer Diagnosed at Later Stages
MDedge News, August 17, 2022
WCLC 2022 Air Pollution Contribution to Lung Cancer May Be Underestimated
MDedge News, August 12, 2022
WCLC 2022 Sugemalimab Offers Another Option in Unresectable NSCLC
Medscape Medical News, August 10, 2022

WCLC 2022 Survival Boost With Neoadjuvant Chemo-Immunotherapy in NSCLC
Medscape Medical News, August 10, 2022
WCLC 2022 PD-LI Is Key to Survival Benefit With Atezolizumab in NSCLC
Medscape Medical News, August 9, 2022

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Popular News from WCLC 2021

Most Community-Based Oncologists Skip Biomarker Testing Fewer than half of community oncologists use biomarker testing to guide patient discussions about treatment, compared with 73% of academic clinicians.
Medscape Medical News, Sep 23, 2021
Air Pollution - Second Leading Cause of Lung Cancer Concerted action, including advocacy from oncologists, is needed to help reduce lung cancer deaths worldwide that are directly attributable to air pollution, say experts.
Medscape Medical News, Sep 13, 2021
POSEIDON: Two ICIs Plus Chemo Up Survival in mNSCLC Patiehts with stage IV non–small cell lung cancer have better outcomes when tremelimumab is added to durvalumab and chemo, a phase 3 trial shows, but questions remain over the role of anti-CTLA-4 agents.
Medscape Medical News, Sep 10, 2021

Previous Coverage